Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Aditya BSL Pharma & Hlthcare Reg Gr
as of 24 Jun 2026, 01:13 AM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Equity / Debt / Cash Split
Equity
96.83%
Cash
3.17%
Equity sector allocation
Basic Materials
0.65%
Healthcare
96.18%
Others
3.17%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
31.62%
63.78%
3Y Returns
+63.78%

Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
31.62%
63.78%
3Y Returns
+48.34%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
31.62%
63.78%
3Y Returns
+45.98%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+13.12%
Fund Manager
Dhaval Shah
Risk Profile
Very High Risk
Expense Ratio
1.94%
Fund Size
₹950.31 Cr
Aditya BSL Pharma & Hlthcare Reg Gr is currently priced at ₹34.03, as of 24 Jun 2026, 01:13 AM. The fund has recorded a change of ₹0.23 (0.68%), indicating its recent movement in the market.
Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.
Aditya BSL Pharma & Hlthcare Reg Gr is an open-ended mutual fund that invests based on its stated objective and benchmark.
Key details:
Asset Size: ₹950.31 Cr
Expense Ratio: 1.94%
Cash Holding: 3.17%
Plan Type: Dividend
Benchmark: BSE Healthcare TR INR
Launch Date: 2019-07-11
Exit Load: 1.00
These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.
Aditya BSL Pharma & Hlthcare Reg Gr has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.
Returns:
1 Month: 1.55%
3 Months: 11.65%
6 Months: 10.27%
1 Year: 13.81%
3 Years: 0.85%
5 Years: 0.85%
Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.
Understanding risk is important before investing. Aditya BSL Pharma & Hlthcare Reg Gr falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.
Risk Level: Very High Risk
The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.
The asset allocation of Aditya BSL Pharma & Hlthcare Reg Gr shows how investments are distributed across asset classes.
Equity Allocation: 96.83%
Cash Allocation: 3.17%
This allocation plays a key role in determining the fund’s risk and return profile.
Aditya BSL Pharma & Hlthcare Reg Gr diversifies its investments across sectors to reduce risk.
Sector Holding Detail
Basic Materials: 0.65%
Healthcare: 96.18%
Sector allocation data helps investors understand which industries the fund is focusing on.
Aditya BSL Pharma & Hlthcare Reg Gr is managed by:
AMC Name: Aditya Birla Sun Life AMC Ltd
A strong fund house with a proven track record can improve investor confidence.
Investors can start investing in Aditya BSL Pharma & Hlthcare Reg Gr with:
Minimum Investment: ₹1,000
This makes the fund accessible for both beginners and experienced investors.
The Aditya BSL Pharma & Hlthcare Reg Gr has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 12.42% |
| Apollo Hospitals Enterprise Ltd | 7.31% |
| Torrent Pharmaceuticals Ltd | 4.75% |
| J.B. Chemicals & Pharmaceuticals Ltd | 4.73% |
| Aurobindo Pharma Ltd | 4.37% |
| Ajanta Pharma Ltd | 3.99% |
| Mankind Pharma Ltd | 3.89% |
| Lupin Ltd | 3.73% |
| Abbott India Ltd | 3.65% |
| Fortis Healthcare Ltd | 3.31% |
| Emcure Pharmaceuticals Ltd | 3.17% |
| Cipla Ltd | 2.98% |
| Shilpa Medicare Ltd | 2.92% |
| Ipca Laboratories Ltd | 2.43% |
| Sai Life Sciences Ltd | 2.26% |
| Procter & Gamble Health Ltd | 2.24% |
| Corona Remedies Ltd | 2.06% |
| Alkem Laboratories Ltd | 2.03% |
| Thyrocare Technologies Ltd | 1.89% |
| Jupiter Life Line Hospitals Ltd | 1.84% |
| Divi's Laboratories Ltd | 1.82% |
| Metropolis Healthcare Ltd | 1.57% |
| Sanofi Consumer Healthcare India Ltd | 1.52% |
| Dr. Lal PathLabs Ltd | 1.38% |
| Pfizer Ltd | 1.36% |
| Dr Reddy's Laboratories Ltd | 1.36% |
| Alembic Pharmaceuticals Ltd | 1.25% |
| Biocon Ltd | 1.23% |
| Gland Pharma Ltd | 1.20% |
| Piramal Pharma Ltd | 1.16% |
| Anthem Biosciences Ltd | 1.13% |
| Vijaya Diagnostic Centre Ltd | 1.08% |
| Medi Assist Healthcare Services Ltd | 1.01% |
| Suraksha Diagnostic Ltd | 1.01% |
| GlaxoSmithKline Pharmaceuticals Ltd | 0.75% |
| Max Healthcare Institute Ltd Ordinary Shares | 0.71% |
| Jubilant Pharmova Ltd | 0.66% |
| Vinati Organics Ltd | 0.65% |
| Clearing Corporation Of India Limited | 3.23% |
| Net Receivables / (Payables) | 0.05% |
The Aditya BSL Pharma & Hlthcare Reg Gr has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 0.65% |
| Healthcare | 96.18% |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Aditya BSL Pharma & Hlthcare Reg Gr:
By signing up I certify terms, conditions & privacy policy